Literature DB >> 18474174

Local adipose tissue renin-angiotensin system.

Lisa A Cassis1, Sara B Police, Frederique Yiannikouris, Sean E Thatcher.   

Abstract

A local renin-angiotensin system (RAS) has been proposed in adipocytes. Adipocytes are a suggested source of components of the RAS, with regulation of their production related to obesity-hypertension. Both angiotensin type 1 and 2 receptors have been localized to adipocytes. Angiotensin II has been demonstrated to regulate adipocyte growth and differentiation, lipid metabolism, and expression and release of adipokines and RAS components, and to promote oxidative stress. Differences in regional expression of RAS components in visceral versus subcutaneous adipose tissue have been suggested as a link between abdominal obesity and cardiovascular disease. Finally, several studies support antihypertensive efficacy of RAS blockade in patients with type 2 diabetes and obesity. Future studies should address the role of adipocyte-specific deficiency of RAS components to definitively determine the relevance of the adipose RAS to normal physiology and to the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474174      PMCID: PMC2702858          DOI: 10.1007/s11906-008-0019-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  42 in total

1.  Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans.

Authors:  G H Goossens; S E McQuaid; A L Dennis; M A van Baak; E E Blaak; K N Frayn; W H M Saris; F Karpe
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

2.  Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography - electrospray ionization - mass spectrometry (LC-ESI-MS).

Authors:  B Bujak-Gizycka; J Madej; P P Wołkow; R Olszanecki; L Drabik; J Rutowski; R Korbut
Journal:  J Physiol Pharmacol       Date:  2007-09       Impact factor: 3.011

3.  Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.

Authors:  Kenichi Matsushita; Yaojiong Wu; Yoshihisa Okamoto; Richard E Pratt; Victor J Dzau
Journal:  Hypertension       Date:  2006-10-23       Impact factor: 10.190

4.  Cross talk between adipocytes and their precursors: relationships with adipose tissue development and blood pressure.

Authors:  G Ailhaud
Journal:  Ann N Y Acad Sci       Date:  1999-11-18       Impact factor: 5.691

5.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

6.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

7.  Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth.

Authors:  R Sarzani; P Marcucci; F Salvi; M Bordicchia; E Espinosa; L Mucci; B Lorenzetti; D Minardi; G Muzzonigro; P Dessì-Fulgheri; A Rappelli
Journal:  Int J Obes (Lond)       Date:  2007-09-18       Impact factor: 5.095

8.  Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs.

Authors:  Christoph Schindler; Peter Bramlage; Martin Thoenes; Carsten Bramlage; Wilhelm Kirch
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 9.  Obesity, essential hypertension and renin-angiotensin system.

Authors:  Julian Segura; Luis M Ruilope
Journal:  Public Health Nutr       Date:  2007-10       Impact factor: 4.022

10.  Location and regulation of rat angiotensinogen messenger RNA.

Authors:  L A Cassis; J Saye; M J Peach
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

View more
  74 in total

Review 1.  The importance of the intrarenal renin-angiotensin system.

Authors:  Juan Carlos Q Velez
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

2.  Regulated renin release from 3T3-L1 adipocytes.

Authors:  Jason D Fowler; Nathan D Johnson; Thomas A Haroldson; Joy A Brintnall; Julio E Herrera; Stephen A Katz; David A Bernlohr
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-17       Impact factor: 4.310

Review 3.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

4.  Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.

Authors:  Andreas Pfützner; Markolf Hanefeld; Lida A Dekordi; Jürgen Müller; Iris Kleine; Winfried Fuchs; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

Review 5.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 6.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 7.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

8.  Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.

Authors:  Yingzi Zhao; Sheila Flavahan; Susan W Leung; Aimin Xu; Paul M Vanhoutte; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

9.  Angiotensin AT1 receptor antagonism by losartan stimulates adipocyte browning via induction of apelin.

Authors:  Dong Young Kim; Mi Jin Choi; Tae Kyung Ko; Na Hyun Lee; Ok-Hee Kim; Hyae Gyeong Cheon
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

Review 10.  The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.

Authors:  Fabrizio Montecucco; Aldo Pende; François Mach
Journal:  Mediators Inflamm       Date:  2009-04-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.